Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adults who want to quit smoking by reducing withdrawal symptoms and cravings associated with tobacco dependence.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorette Invisipatch is a nicotine replacement product used to manage tobacco dependence and support quitting attempts. - Smoking cessation: reduces cravings and withdrawal symptoms to aid quitting. - Tobacco dependence: delivers steady nicotine levels to facilitate gradual reduction of cigarette use. - Relapse prevention: helps maintain abstinence after an initial quit attempt.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbance: insomnia or vivid dreams. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Cardiovascular events: chest pain, palpitations, or hypertension. - Dizziness or fainting: especially when standing quickly. - Severe skin reaction: blistering or extensive rash.

Precautions should be observed when using Nicorette Invisipatch to ensure safe and effective use. - Cardiovascular assessment: evaluate heart disease before initiating therapy. - Comprehensive quit plan: use as part of counseling and behavioral support. - Allergy check: avoid if hypersensitive to nicotine or patch adhesives. - Concomitant nicotine products: do not combine with other nicotine replacement therapies. - Keep out of reach of children: store securely to prevent accidental exposure. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicorette Invisipatch may interact with other medicines; awareness of potential interactions is important. Major Interactions (Avoid): - Other nicotine replacement therapies: risk of nicotine overdose. - Monoamine oxidase inhibitors: may amplify nicotine’s cardiovascular effects. Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., cimetidine): can increase nicotine plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Certain antidepressants (SSRIs): may alter nicotine metabolism and affect mood.